Ladenburg Thalmann Financial Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$168K	Buy	1,023 +197	+24%	+$36.4K	﹤0.01%	2642
2019 Q3	$126K	Buy	826 +370	+81%	+$60.6K	﹤0.01%	2783
2019 Q2	$59K	Buy	+456	New	+$54.1K	﹤0.01%	3348
2017 Q1	–	Sell	-13	Closed	-$1K	–	4892
2016 Q4	$1K	Buy	+13	New	+$800	﹤0.01%	4655
2015 Q3	–	Sell	-50	Closed	-$3K	–	4651
2015 Q2	$3K	Buy	+50	New	+$2.65K	﹤0.01%	4228

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LKFT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 24% in Q4 2019, buying an estimated $36.4K and bringing the position to 1,023 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Ladenburg Thalmann Financial Services first reported a position in LKFT in Q2 2015 and has held it in 5 quarters since. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,023 shares of Lakefront Biotherapeutics American Depositary Shares worth $168K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 197 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $36.4K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2642 holding.
Ladenburg Thalmann Financial Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 5 quarters since.
137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.